Close

Needham & Company Raises Price Target on Inogen (INGN) to $64 Following 2Q Beat

Go back to Needham & Company Raises Price Target on Inogen (INGN) to $64 Following 2Q Beat

Inogen (INGN) Tops Q2 EPS by 5c

August 4, 2016 5:02 PM EDT

Inogen (NASDAQ: INGN) reported Q2 EPS of $0.25, $0.05 better than the analyst estimate of $0.20. Revenue for the quarter came in at $64.6 million versus the consensus estimate of $52.44 million.

For earnings history and earnings-related data on Inogen (INGN) click here.

... More

Trading Radar for 8/4: Kellogg (K), MGM Resorts (MGM), Activision (ATVI), FireEye (FEYE), Weight Watchers (WTW) Report

August 3, 2016 2:51 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 264kContinuing Claims - no Street consensus

Earnings:

AAC Holdings (NYSE: AAC) - consensus EPS $0.23
AGCO Corp. (Nasdaq: AGCO) - consensus EPS $0.92
ANI Pharma (Nasdaq: ANIP) - consensus EPS $0.77
Acceleron Pharma (NYSE: XLRN) - consensus loss $0.50
Agios Pharma (Nasdaq:... More